Abstract
CYSTIC fibrosis (CF) is a lethal inherited disorder affecting about 1 in 2,000 Caucasians. The major cause of morbidity is permanent lung damage resulting from ion transport abnormalities in airway epithelia that lead to mucus accumulation and bacterial colonization. CF is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene1 that encodes a cyclic-AMP-regulated chloride channel2,3. Cyclic-AMP-regulated chloride conductances are altered in airway epithelia from CF patients4–6, suggesting that the functional expression of CFTR in the airways of CF patients may be a strategy for treatment. Transgenic mice7–9 with a disrupted cftr gene are appropriate for testing gene therapy protocols. Here we report the use of liposomes to deliver a CFTR expression plasmid to epithelia of the airway and to alveoli deep in the lung, leading to the correction of the ion conductance defects found in the trachea of transgenic (cf/cf) mice. These studies illustrate the feasibility of gene therapy for the pulmonary aspects of CF in humans.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Riordan, J. R. et al. Science 245, 1066–1073 (1989).
Anderson, M. P. et al. Science 253, 202–205 (1991).
Bear, C. E. et al. Cell 68, 809–818 (1992).
Anderson, M. P. & Welsh, M. J. Proc. natn. Acad. Sci. U.S.A. 88, 6003–6007 (1991).
Wagner, J. A. et al. Nature 349, 793–796 (1991).
Chan, H-C., Goldstein, J. & Nelson, D. J. Am. J. Physiol. 262, C1273–C1283 (1992).
Snouwaert, J. N. et al. Science 257, 1083–1088 (1992).
Dorin, J. R. et al. Nature 359, 211–215 (1992).
Colledge, W. H., Ratcliff, R., Foster, D., Williamson, R. & Evans, M. J. Lancet 340, 680 (1992).
Yoshimura, K. et al. Nucleic Acids Res. 20, 3233–3240 (1992).
Stribling, R., Brunette, E., Ligitt, D., Gaensler, K. & Debs, R. Proc. natn. Acad. Sci. U.S.A. 89, 11277–11281 (1992).
Drumm et al. Cell 62, 1227–1233 (1990).
Kartner, N. et al. Cell 64, 681–691 (1991).
Trezise, A. E. O. & Buchwald, M. Nature 353, 434–437 (1991).
Trezise, A. E. O. et al. EMBO J. 11, 4291–4303 (1992).
Trezise, A. E. O., Chambers, J. A., Wardle, C. J., Gould, S. & Harris, A. Hum. molec. Genet. (in the press).
Ratcliff, R. et al. Nature Genet. (in the press).
Boucher, R. C., Stutts, M. J., Knowles, M. R., Cantley, L. & Gatzy, J. T. J. clin. Invest. 78, 1245–1252 (1986).
Cotton, C. U., Stutts, M. J., Knowles, M. R., Gatzy, J. T. & Boucher, R. C. J. clin. Invest. 79, 80–85 (1987).
Knowles, M. R. et al. Science 221, 1067–1070 (1983).
Knowles, M. R. et al. N. Engl. J. Med. 322, 1189–1194 (1990).
App, E. M. et al. Am. Rev. resp. Dis. 141, 605–612 (1990).
Williumsen, N. J. & Boucher, R. C. Am. J. Physiol. 256, C226–C233 (1989).
McCann, J. D., Matsuda, J., Garcia, M., Kaczorowski, G. & Welsh, M. J. Am. J. Physiol. 258, L334–L342 (1990).
Crawford, I. et al. Proc. natn. Acad. Sci. U.S.A. 88, 9262–9266 (1991).
Zeitlin, P. L. et al. Proc. natn. Acad. Sci. U.S.A. 89, 1344–1347 (1991).
Cheng, S. H. et al. Cell 63, 827–834 (1990).
Gregory, R. J. et al. Nature 347, 382–386 (1990).
Kozak, M. Cell 44, 283–292 (1986).
Simmons, D. M., Arriza, J. L. & Swanson, L. W. J. Histochem. 12, 169–181 (1989).
Cuthbert, A. W., Brayden, D. J., Dunne, A., Smyth, R. L. & Wallwork, J. Br. J. clin. Pharm. 29, 227–234 (1990).
Clarke, L. L. et al. Science 257, 1125–1128 (1992).
Smith, S. N., Alton, E. W. F. W. & Geddes, D. M. Clin. Sci. 82, 667–672 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hyde, S., Gill, D., Higgins, C. et al. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 362, 250–255 (1993). https://doi.org/10.1038/362250a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/362250a0
This article is cited by
-
Defective small intestinal anion secretion, dipeptide absorption, and intestinal failure in suckling NBCe1-deficient mice
Pflügers Archiv - European Journal of Physiology (2016)
-
Overcoming the Cystic Fibrosis Sputum Barrier to Leading Adeno-associated Virus Gene Therapy Vectors
Molecular Therapy (2014)
-
Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung
Gene Therapy (2011)
-
Use of ultrasound to enhance nonviral lung gene transfer in vivo
Gene Therapy (2007)
-
Optimizing Aerosol Gene Delivery and Expression in the Ovine Lung
Molecular Therapy (2007)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
